2014
DOI: 10.1111/pan.12519
|View full text |Cite
|
Sign up to set email alerts
|

Analgesic effect and adverse events of dexmedetomidine as additive for pediatric caudal anesthesia: a meta‐analysis

Abstract: Dexmedetomidine as an additive to local anesthetic provides a significantly longer postoperative analgesia with comparable adverse effects and hemodynamic changes, when compared to local anesthetics alone. There were insufficient data of the effects of different concentrations of dexmedetomidine; further studies are required to explore this issue.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

7
35
0
2

Year Published

2016
2016
2021
2021

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 52 publications
(44 citation statements)
references
References 31 publications
(59 reference statements)
7
35
0
2
Order By: Relevance
“…For RCTs, two investigators (RW, CEZ) independently used the Cochrane Collaboration’s tool to assess risk of bias as low, unclear or high 14. The ‘risk of bias’ table of a Cochrane review includes sequence generation (selection bias), allocation sequence concealment (selection bias), blinding of participants and personnel (performance bias), blinding of outcome assessment (detection bias), incomplete outcome data (attrition bias), selective outcome reporting (reporting bias), and other potential sources of bias 15. For observational studies, two researchers (HY, JH) independently used the ‘risk of bias in non-randomized studies of interventions’ (ROBINS-I) assessment tool for assessing risk of bias as low, moderate, serious, critical or no information 16.…”
Section: Methodsmentioning
confidence: 99%
“…For RCTs, two investigators (RW, CEZ) independently used the Cochrane Collaboration’s tool to assess risk of bias as low, unclear or high 14. The ‘risk of bias’ table of a Cochrane review includes sequence generation (selection bias), allocation sequence concealment (selection bias), blinding of participants and personnel (performance bias), blinding of outcome assessment (detection bias), incomplete outcome data (attrition bias), selective outcome reporting (reporting bias), and other potential sources of bias 15. For observational studies, two researchers (HY, JH) independently used the ‘risk of bias in non-randomized studies of interventions’ (ROBINS-I) assessment tool for assessing risk of bias as low, moderate, serious, critical or no information 16.…”
Section: Methodsmentioning
confidence: 99%
“…The use of adjuvants, such as clonidine, opioids, ketamine, and midazolam, with epidural local anesthetics improves the duration and quality of analgesia and decreases the potential risk of systemic toxicity and seizure and the incidence of motor block by decreasing the dose of the local anesthetic 67. However, opioids, such as fentanyl and morphine, which have traditionally been used as adjuvants to epidural local anesthetics, are associated with side effects of pruritus, urinary retention, nausea and vomiting, and respiratory depression.…”
Section: Introductionmentioning
confidence: 99%
“…However, opioids, such as fentanyl and morphine, which have traditionally been used as adjuvants to epidural local anesthetics, are associated with side effects of pruritus, urinary retention, nausea and vomiting, and respiratory depression. Dexmedetomidine, which is a highly selective α-2 adrenergic agonist with sedative and analgesic properties, has recently been used as an adjuvant to general and regional anesthesia in both adults and children 6789. As of yet, dexmedetomidine has not been approved for use in the pediatric population in any country 10.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…When used as an adjuvant to regional anesthesia or a nerve block, dexmedetomidine improves the quality and duration of anesthesia [56]. The current volume of the Korean Journal of Anesthesiology presents an interesting clinical study [7] and a case report [8] about the off-label use of dexmedetomidine.…”
mentioning
confidence: 99%